Health CanadaGeneral Alert
Contaminated Heparin Used in Trillium Coatings Applied to Selected Cardiopulmonary Bypass Products - Notice to Hospitals
Published: May 30, 2008Recall ID: 24257Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
Contaminated Heparin Used in Trillium Coatings Applied to Selected Cardiopulmonary Bypass Products - Notice to Hospitals
Recalling Firm: Marketed health products
Product Description & Identification
Contaminated Heparin Used in Trillium Coatings Applied to Selected Cardiopulmonary Bypass Products - Notice to Hospitals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24257 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/contaminated-heparin-used-trillium-coatings-applied-selected-cardiopulmonary-bypass |
| Title | Contaminated Heparin Used in Trillium Coatings Applied to Selected Cardiopulmonary Bypass Products - Notice to Hospitals |
| Archived | 1 |
| Category | Medical devices |
| Last updated | 2008-05-30 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Contaminated Heparin Used in Trillium Coatings Applied to Selected Cardiopulmonary Bypass Products - Notice to Hospitals Check if your household is affected: https://therecallfile.com/recalls/contaminated-heparin-used-in-trillium-coatings-applied-to-selected-car/CANADA-24257
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordContaminated Heparin Used in Trillium Coatings Applied to Selected Cardiopulmonary Bypass Products - Notice to Hospitals